Proceedings: Testosterone potentiated radiophosphorus therapy of osseous metastases in prostatic cancer.
D000284:Administration, Oral; D000368:Aged; D001859:Bone Neoplasms / Q000188:drug therapy / Q000532:radiotherapy*; D005260:Female; D006410:Hematopoiesis / Q000528:radiation effects; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000188:drug therapy / Q000532:radiotherapy; D010761:Phosphorus Radioisotopes / Q000008:administration & dosage / Q000627:therapeutic use*; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000532:radiotherapy*; D013117:Spinal Cord Compression / Q000209:etiology; D013125:Spinal Neoplasms / Q000150:complications / Q000188:drug therapy / Q000532:radiotherapy; D013739:Testosterone / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000209:etiology
D010761:Phosphorus Radioisotopes; D013739:Testosterone